Q/C Technologies, Inc. Production Related Impairments or Charges
Q/C Technologies, Inc. (QCLS) reported Production Related Impairments or Charges of $18.68 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ProductionRelatedImpairmentsOrCharges · last filed 2021-03-01
- Q/C Technologies, Inc. production related impairments or charges for the quarter ending 2020-06-30 was $18.68K.
- Q/C Technologies, Inc. production related impairments or charges for the quarter ending 2020-03-31 was $3.88K.
- Q/C Technologies, Inc. production related impairments or charges for the quarter ending 2019-09-30 was $96.30K, a 56.17% decline year-over-year.
- Q/C Technologies, Inc. production related impairments or charges for the quarter ending 2019-03-31 was $0.00.
- Q/C Technologies, Inc. production related impairments or charges for fiscal 2020 was $18.68K.
| Period end | Production Related Impairments or Charges 3 month | Production Related Impairments or Charges 6 month | Production Related Impairments or Charges 9 month | Production Related Impairments or Charges 12 month |
|---|---|---|---|---|
| 2020-12-31 | $18.68K 10-K · filed 2021-03-01 | |||
| 2020-06-30 | $18.68K 10-Q · filed 2020-08-14 | $18.68K 10-Q · filed 2020-08-14 | ||
| 2020-03-31 | $3.88K 10-Q · filed 2020-05-15 | |||
| 2019-09-30 | $96.30K 10-Q · filed 2019-11-14 | $98.35K 10-Q · filed 2019-11-14 | ||
| 2019-03-31 | $0.00 10-Q · filed 2020-05-15 | |||
| 2018-09-30 | $219.70K 10-Q · filed 2019-11-14 | $251.98K 10-Q · filed 2019-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |